Literature DB >> 20592206

Lateral mobility of nicotinic acetylcholine receptors on neurons is determined by receptor composition, local domain, and cell type.

Catarina C Fernandes1, Darwin K Berg, David Gómez-Varela.   

Abstract

The lateral mobility of surface receptors can define the signaling properties of a synapse and rapidly change synaptic function. Here we use single-particle tracking with Quantum Dots to follow nicotinic acetylcholine receptors (nAChRs) on the surface of chick ciliary ganglion neurons in culture. We find that both heteropentameric alpha3-containing receptors (alpha3*-nAChRs) and homopentameric alpha7-containing receptors (alpha7-nAChRs) access synaptic domains by lateral diffusion. They have comparable mobilities and display Brownian motion in extrasynaptic space but are constrained and move more slowly in synaptic space. The two receptor types differ in the nature of their synaptic restraints. Disruption of lipid rafts, PDZ-containing scaffolds, and actin filaments each increase the mobility of alpha7-nAChRs in synaptic space while collapse of microtubules has no effect. The opposite is seen for alpha3*-nAChRs where synaptic mobility is increased only by microtubule collapse and not the other manipulations. Other differences are found for regulation of alpha3*-nAChR and alpha7-nAChR mobilities in extrasynaptic space. Most striking are effects on the immobile populations of alpha7-nAChRs and alpha3*-nAChRs. Disruption of either lipid rafts or PDZ scaffolds renders half of the immobile alpha3*-nAChRs mobile without changing the proportion of immobile alpha7-nAChRs. Similar results were obtained with chick sympathetic ganglion neurons, though regulation of receptor mobility differed in at least one respect from that seen with ciliary ganglion neurons. Control of nAChR lateral mobility, therefore, is determined by mechanisms that are domain specific, receptor subtype dependent, and cell-type constrained. The outcome is a system that could tailor nicotinic signaling capabilities to specific needs of individual locations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592206      PMCID: PMC2913715          DOI: 10.1523/JNEUROSCI.6236-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  88 in total

1.  Postsynaptic neuroligin enhances presynaptic inputs at neuronal nicotinic synapses.

Authors:  William G Conroy; Qiang Nai; Brendon Ross; Gregory Naughton; Darwin K Berg
Journal:  Dev Biol       Date:  2007-04-21       Impact factor: 3.582

2.  EphB receptors co-distribute with a nicotinic receptor subtype and regulate nicotinic downstream signaling in neurons.

Authors:  Zhaoping Liu; William G Conroy; Tamara M Stawicki; Qiang Nai; Robert A Neff; Darwin K Berg
Journal:  Mol Cell Neurosci       Date:  2008-03-18       Impact factor: 4.314

Review 3.  Glutamate receptor dynamics in dendritic microdomains.

Authors:  Thomas M Newpher; Michael D Ehlers
Journal:  Neuron       Date:  2008-05-22       Impact factor: 17.173

Review 4.  Measurement and characteristics of neurotransmitter receptor surface trafficking (Review).

Authors:  Laurent Groc; Daniel Choquet
Journal:  Mol Membr Biol       Date:  2008-05       Impact factor: 2.857

5.  Rapid and modifiable neurotransmitter receptor dynamics at a neuronal synapse in vivo.

Authors:  Corey M McCann; Juan Carlos Tapia; Han Kim; Jay S Coggan; Jeff W Lichtman
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

6.  Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.

Authors:  Robert S Bitner; William H Bunnelle; David J Anderson; Clark A Briggs; Jerry Buccafusco; Peter Curzon; Michael W Decker; Jennifer M Frost; Jens Halvard Gronlien; Earl Gubbins; Jinhe Li; John Malysz; Stella Markosyan; Kennan Marsh; Michael D Meyer; Arthur L Nikkel; Richard J Radek; Holly M Robb; Daniel Timmermann; James P Sullivan; Murali Gopalakrishnan
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

7.  Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation.

Authors:  Yaroslav Teper; Douglas Whyte; Elizabeth Cahir; Henry A Lester; Sharon R Grady; Michael J Marks; Bruce N Cohen; Carlos Fonck; Tristan McClure-Begley; J Michael McIntosh; Cesar Labarca; Andrew Lawrence; Feng Chen; Ilse Gantois; Philip J Davies; Steven Petrou; Mark Murphy; John Waddington; Malcolm K Horne; Samuel F Berkovic; John Drago
Journal:  J Neurosci       Date:  2007-09-19       Impact factor: 6.167

8.  Adenomatous polyposis coli plays a key role, in vivo, in coordinating assembly of the neuronal nicotinic postsynaptic complex.

Authors:  Madelaine M Rosenberg; Fang Yang; Monica Giovanni; Jesse L Mohn; Murali K Temburni; Michele H Jacob
Journal:  Mol Cell Neurosci       Date:  2008-03-04       Impact factor: 4.314

9.  Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic alpha 7 nicotinic receptors.

Authors:  Nicolas Wanaverbecq; Alexey Semyanov; Ivan Pavlov; Matthew C Walker; Dimitri M Kullmann
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

10.  Surface mobility of postsynaptic AMPARs tunes synaptic transmission.

Authors:  Martin Heine; Laurent Groc; Renato Frischknecht; Jean-Claude Béïque; Brahim Lounis; Gavin Rumbaugh; Richard L Huganir; Laurent Cognet; Daniel Choquet
Journal:  Science       Date:  2008-04-11       Impact factor: 47.728

View more
  30 in total

1.  Live-cell imaging of single receptor composition using zero-mode waveguide nanostructures.

Authors:  Christopher I Richards; Khai Luong; Rahul Srinivasan; Stephen W Turner; Dennis A Dougherty; Jonas Korlach; Henry A Lester
Journal:  Nano Lett       Date:  2012-06-08       Impact factor: 11.189

Review 2.  Synaptic neurotransmitter-gated receptors.

Authors:  Trevor G Smart; Pierre Paoletti
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

3.  PMCA2 via PSD-95 controls calcium signaling by α7-containing nicotinic acetylcholine receptors on aspiny interneurons.

Authors:  David Gómez-Varela; Manuela Schmidt; Jeff Schoellerman; Eric C Peters; Darwin K Berg
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

4.  Lateral mobility of presynaptic α7-containing nicotinic receptors and its relevance for glutamate release.

Authors:  David Gomez-Varela; Darwin K Berg
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

5.  The α7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane.

Authors:  José O Colón-Sáez; Jerrel L Yakel
Journal:  J Physiol       Date:  2011-05-03       Impact factor: 5.182

6.  Regulation of presynaptic strength by controlling Ca2+ channel mobility: effects of cholesterol depletion on release at the cone ribbon synapse.

Authors:  Aaron J Mercer; Robert J Szalewski; Skyler L Jackman; Matthew J Van Hook; Wallace B Thoreson
Journal:  J Neurophysiol       Date:  2012-03-21       Impact factor: 2.714

7.  A novel mechanism for nicotinic potentiation of glutamatergic synapses.

Authors:  Andrew W Halff; David Gómez-Varela; Danielle John; Darwin K Berg
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

8.  Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.

Authors:  Barbora Melkes; Lucie Hejnova; Jiri Novotny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-06       Impact factor: 3.000

Review 9.  Structure activity relationship of synaptic and junctional neurotransmission.

Authors:  Raj K Goyal; Arun Chaudhury
Journal:  Auton Neurosci       Date:  2013-03-25       Impact factor: 3.145

Review 10.  Labeling of neuronal receptors and transporters with quantum dots.

Authors:  Jerry C Chang; Oleg Kovtun; Randy D Blakely; Sandra J Rosenthal
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.